{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:15:42Z","timestamp":1791123342216,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"33","license":[{"start":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T00:00:00Z","timestamp":1245628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T00:00:00Z","timestamp":1245628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2009,8,20]]},"DOI":"10.1038\/onc.2009.156","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T10:08:18Z","timestamp":1245665298000},"page":"2959-2968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor"],"prefix":"10.1038","volume":"28","author":[{"given":"S","family":"Confalonieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Quarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Goisis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Nuciforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Donzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Jodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P P","family":"Di Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,22]]},"reference":[{"key":"BFonc2009156_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2005.08.016","volume":"123","author":"S Adhikary","year":"2005","unstructured":"Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R et al. (2005). The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123: 409\u2013421.","journal-title":"Cell"},{"key":"BFonc2009156_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ccr.2008.06.001","volume":"14","author":"F Bernassola","year":"2008","unstructured":"Bernassola F, Karin M, Ciechanover A, Melino G . (2008). The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14: 10\u201321.","journal-title":"Cancer Cell"},{"key":"BFonc2009156_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/carcin\/bgm268","volume":"29","author":"LR Borlado","year":"2008","unstructured":"Borlado LR, Mendez J . (2008). CDC6: from DNA replication to cell cycle checkpoints and oncogenesis. Carcinogenesis 29: 237\u2013243.","journal-title":"Carcinogenesis"},{"key":"BFonc2009156_CR4","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/sj.emboj.7601144","volume":"25","author":"G Buchwald","year":"2006","unstructured":"Buchwald G, van der Stoop P, Weichenrieder O, Perrakis A, van Lohuizen M, Sixma TK . (2006). Structure and E3-ligase activity of the Ring\u2013Ring complex of polycomb proteins Bmi1 and Ring1b. EMBO J 25: 2465\u20132474.","journal-title":"EMBO J"},{"key":"BFonc2009156_CR5","doi-asserted-by":"publisher","first-page":"8147","DOI":"10.1158\/0008-5472.CAN-05-3489","volume":"66","author":"M Capra","year":"2006","unstructured":"Capra M, Nuciforo PG, Confalonieri S, Quarto M, Bianchi M, Nebuloni M et al. (2006). Frequent alterations in the expression of serine\/threonine kinases in human cancers. Cancer Res 66: 8147\u20138154.","journal-title":"Cancer Res"},{"key":"BFonc2009156_CR6","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.cell.2005.03.037","volume":"121","author":"D Chen","year":"2005","unstructured":"Chen D, Kon N, Li M, Zhang W, Qin J, Gu W . (2005). ARF-BP1\/Mule is a critical mediator of the ARF tumor suppressor. Cell 121: 1071\u20131083.","journal-title":"Cell"},{"key":"BFonc2009156_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1042\/bst0310474","volume":"31","author":"A Ciechanover","year":"2003","unstructured":"Ciechanover A . (2003). The ubiquitin proteolytic system and pathogenesis of human diseases: a novel platform for mechanism-based drug targeting. Biochem Soc Trans 31: 474\u2013481.","journal-title":"Biochem Soc Trans"},{"key":"BFonc2009156_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/jhep.2002.30316","volume":"35","author":"A Ciechanover","year":"2002","unstructured":"Ciechanover A, Schwartz AL . (2002). Ubiquitin-mediated degradation of cellular proteins in health and disease. Hepatology 35: 3\u20136.","journal-title":"Hepatology"},{"key":"BFonc2009156_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-3835(01)00770-4","volume":"177","author":"Y Dong","year":"2002","unstructured":"Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M . (2002). Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma. Cancer Lett 177: 13\u201319.","journal-title":"Cancer Lett"},{"key":"BFonc2009156_CR10","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1073\/pnas.0400177101","volume":"101","author":"G Fiucci","year":"2004","unstructured":"Fiucci G, Beaucourt S, Duflaut D, Lespagnol A, Stumptner-Cuvelette P, Geant A et al. (2004). Siah-1b is a direct transcriptional target of p53: identification of the functional p53 responsive element in the siah-1b promoter. Proc Natl Acad Sci USA 101: 3510\u20133515.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009156_CR11","doi-asserted-by":"publisher","first-page":"31279","DOI":"10.1074\/jbc.C200125200","volume":"277","author":"A Gautreau","year":"2002","unstructured":"Gautreau A, Manent J, Fievet B, Louvard D, Giovannini M, Arpin M . (2002). Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin\u2013proteasome pathway. J Biol Chem 277: 31279\u201331282.","journal-title":"J Biol Chem"},{"key":"BFonc2009156_CR12","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1091\/mbc.e07-02-0173","volume":"18","author":"JR Hall","year":"2007","unstructured":"Hall JR, Kow E, Nevis KR, Lu CK, Luce KS, Zhong Q et al. (2007). Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage. Mol Biol Cell 18: 3340\u20133350.","journal-title":"Mol Biol Cell"},{"key":"BFonc2009156_CR13","first-page":"6414","volume":"62","author":"KA Hassan","year":"2002","unstructured":"Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D et al. (2002). Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res 62: 6414\u20136417.","journal-title":"Cancer Res"},{"key":"BFonc2009156_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A . (1998). The ubiquitin system. Annu Rev Biochem 67: 425\u2013479.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2009156_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tibs.2005.02.004","volume":"30","author":"T Hoppe","year":"2005","unstructured":"Hoppe T . (2005). Multiubiquitylation by E4 enzymes: \u2018one size\u2019 doesn't fit all. Trends Biochem Sci 30: 183\u2013187.","journal-title":"Trends Biochem Sci"},{"key":"BFonc2009156_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.yexcr.2005.04.001","volume":"308","author":"J Kallijarvi","year":"2005","unstructured":"Kallijarvi J, Lahtinen U, Hamalainen R, Lipsanen-Nyman M, Palvimo JJ, Lehesjoki AE . (2005). TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase. Exp Cell Res 308: 146\u2013155.","journal-title":"Exp Cell Res"},{"key":"BFonc2009156_CR17","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/sj.onc.1207298","volume":"23","author":"M Kim","year":"2004","unstructured":"Kim M, Tezuka T, Tanaka K, Yamamoto T . (2004). Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. Oncogene 23: 1645\u20131655.","journal-title":"Oncogene"},{"key":"BFonc2009156_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S et al. (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844\u2013847.","journal-title":"Nat Med"},{"key":"BFonc2009156_CR19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.embor.7400624","volume":"7","author":"E Lau","year":"2006","unstructured":"Lau E, Zhu C, Abraham RT, Jiang W . (2006). The functional role of Cdc6 in S\u2013G2\/M in mammalian cells. EMBO R 7: 425\u2013430.","journal-title":"EMBO R"},{"key":"BFonc2009156_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1097-2765(01)00241-6","volume":"7","author":"J Liu","year":"2001","unstructured":"Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL et al. (2001). Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7: 927\u2013936.","journal-title":"Mol Cell"},{"key":"BFonc2009156_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrc2248","volume":"7","author":"M Lobrich","year":"2007","unstructured":"Lobrich M, Jeggo PA . (2007). The impact of a negligent G2\/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer 7: 861\u2013869.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2009156_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S1097-2765(01)00242-8","volume":"7","author":"SI Matsuzawa","year":"2001","unstructured":"Matsuzawa SI, Reed JC . (2001). Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7: 915\u2013926.","journal-title":"Mol Cell"},{"key":"BFonc2009156_CR23","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/bies.20304","volume":"27","author":"G Meroni","year":"2005","unstructured":"Meroni G, Diez-Roux G . (2005). TRIM\/RBCC, a novel class of \u2018single protein RING finger\u2019 E3 ubiquitin ligases. Bioessays 27: 1147\u20131157.","journal-title":"Bioessays"},{"key":"BFonc2009156_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1126\/science.1127085","volume":"315","author":"D Mukhopadhyay","year":"2007","unstructured":"Mukhopadhyay D, Riezman H . (2007). Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315: 201\u2013205.","journal-title":"Science"},{"key":"BFonc2009156_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrc1881","volume":"6","author":"KI Nakayama","year":"2006","unstructured":"Nakayama KI, Nakayama K . (2006). Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 6: 369\u2013381.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2009156_CR26","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1172\/JCI24862","volume":"115","author":"F Nicassio","year":"2005","unstructured":"Nicassio F, Bianchi F, Capra M, Vecchi M, Confalonieri S, Bianchi M et al. (2005). A cancer-specific transcriptional signature in human neoplasia. J Clin Invest 115: 3015\u20133025.","journal-title":"J Clin Invest"},{"key":"BFonc2009156_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1083\/jcb.200311044","volume":"165","author":"M Oehlmann","year":"2004","unstructured":"Oehlmann M, Score AJ, Blow JJ . (2004). The role of Cdc6 in ensuring complete genome licensing and S phase checkpoint activation. J Cell Biol 165: 181\u2013190.","journal-title":"J Cell Biol"},{"key":"BFonc2009156_CR28","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1158\/1078-0432.CCR-07-2218","volume":"14","author":"RZ Orlowski","year":"2008","unstructured":"Orlowski RZ, Kuhn DJ . (2008). Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin Cancer Res 14: 1649\u20131657.","journal-title":"Clin Cancer Res"},{"key":"BFonc2009156_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0962-8924(03)00024-2","volume":"13","author":"C Pelizon","year":"2003","unstructured":"Pelizon C . (2003). Down to the origin: Cdc6 protein and the competence to replicate. Trends Cell Biol 13: 110\u2013113.","journal-title":"Trends Cell Biol"},{"key":"BFonc2009156_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physiolgenomics.2000.4.2.147","volume":"4","author":"LE Scarafia","year":"2000","unstructured":"Scarafia LE, Winter A, Swinney DC . (2000). Quantitative expression analysis of the cellular specificity of HECT-domain ubiquitin E3 ligases. Physiol Genomics 4: 147\u2013153.","journal-title":"Physiol Genomics"},{"key":"BFonc2009156_CR31","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1016\/j.febslet.2006.07.046","volume":"580","author":"R Schauvliege","year":"2006","unstructured":"Schauvliege R, Janssens S, Beyaert R . (2006). Pellino proteins are more than scaffold proteins in TLR\/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases. FEBS Lett 580: 4697\u20134702.","journal-title":"FEBS Lett"},{"key":"BFonc2009156_CR32","first-page":"149","volume":"286","author":"S Sigismund","year":"2004","unstructured":"Sigismund S, Polo S, Di Fiore PP . (2004). Signaling through monoubiquitination. Curr Top Microbiol Immunol 286: 149\u2013185.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFonc2009156_CR33","first-page":"4000","volume":"60","author":"JC Soria","year":"2000","unstructured":"Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK et al. (2000). Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 60: 4000\u20134004.","journal-title":"Cancer Res"},{"key":"BFonc2009156_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1593\/neo.06376","volume":"8","author":"Y Sun","year":"2006","unstructured":"Sun Y . (2006). E3 Ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8: 645\u2013654.","journal-title":"Neoplasia"},{"key":"BFonc2009156_CR35","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1128\/MCB.23.6.2109-2122.2003","volume":"23","author":"GG Toby","year":"2003","unstructured":"Toby GG, Gherraby W, Coleman TR, Golemis EA . (2003). A novel RING finger protein, human enhancer of invasion 10, alters mitotic progression through regulation of cyclin B levels. Mol Cell Biol 23: 2109\u20132122.","journal-title":"Mol Cell Biol"},{"key":"BFonc2009156_CR36","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/sj.onc.1210858","volume":"27","author":"M Vecchi","year":"2008","unstructured":"Vecchi M, Confalonieri S, Nuciforo P, Vigano MA, Capra M, Bianchi M et al. (2008). Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene 27: 2148\u20132158.","journal-title":"Oncogene"},{"key":"BFonc2009156_CR37","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al. (2003). A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349: 546\u2013553.","journal-title":"N Engl J Med"},{"key":"BFonc2009156_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/BF01269891","volume":"123","author":"A Wang","year":"1997","unstructured":"Wang A, Yoshimi N, Ino N, Tanaka T, Mori H . (1997). Overexpression of cyclin B1 in human colorectal cancers. J Cancer Res Clin Oncol 123: 124\u2013127.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFonc2009156_CR39","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1371\/journal.pgen.0030139","volume":"3","author":"JO Ward","year":"2007","unstructured":"Ward JO, Reinholdt LG, Motley WW, Niswander LM, Deacon DC, Griffin LB et al. (2007). Mutation in mouse hei10, an e3 ubiquitin ligase, disrupts meiotic crossing over. PLoS Genet 3: e139.","journal-title":"PLoS Genet"},{"key":"BFonc2009156_CR40","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1016\/j.febslet.2007.09.062","volume":"581","author":"A Weiss","year":"2007","unstructured":"Weiss A, Baumgartner M, Radziwill G, Dennler J, Moelling K . (2007). c-Src is a PDZ interaction partner and substrate of the E3 ubiquitin ligase Ligand-of-Numb protein X1. FEBS Lett 581: 5131\u20135136.","journal-title":"FEBS Lett"},{"key":"BFonc2009156_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1128\/MCB.01355-06","volume":"27","author":"Y Xia","year":"2007","unstructured":"Xia Y, Wang J, Xu S, Johnson GL, Hunter T, Lu Z . (2007). MEKK1 mediates the ubiquitination and degradation of c-Jun in response to osmotic stress. Mol Cell Biol 27: 510\u2013517.","journal-title":"Mol Cell Biol"},{"key":"BFonc2009156_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00432-002-0359-9","volume":"128","author":"M Yasuda","year":"2002","unstructured":"Yasuda M, Takesue F, Inutsuka S, Honda M, Nozoe T, Korenaga D . (2002). Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study. J Cancer Res Clin Oncol 128: 412\u2013416.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFonc2009156_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2004.11.004","volume":"326","author":"SY Yoon","year":"2005","unstructured":"Yoon SY, Lee Y, Kim JH, Chung AS, Joo JH, Kim CN et al. (2005). Over-expression of human UREB1 in colorectal cancer: HECT domain of human UREB1 inhibits the activity of tumor suppressor p53 protein. Biochem Biophys Res Commun 326: 7\u201317.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2009156_CR44","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ncb1727","volume":"10","author":"X Zhao","year":"2008","unstructured":"Zhao X, Heng JI, Guardavaccaro D, Jiang R, Pagano M, Guillemot F et al. (2008). The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nat Cell Biol 10: 643\u2013653.","journal-title":"Nat Cell Biol"},{"key":"BFonc2009156_CR45","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.cell.2005.06.009","volume":"121","author":"Q Zhong","year":"2005","unstructured":"Zhong Q, Gao W, Du F, Wang X . (2005). Mule\/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121: 1085\u20131095.","journal-title":"Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2009156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009156","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:28:47Z","timestamp":1647880127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2009156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,22]]},"references-count":45,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2009,8,20]]}},"alternative-id":["BFonc2009156"],"URL":"https:\/\/doi.org\/10.1038\/onc.2009.156","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,22]]},"assertion":[{"value":"15 October 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}